Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Open-market sale Chief Medical Officer sold 19,175 shares at $18.12 ($347,405)
  2. 4 Open-market sale Chief Medical Officer sold 19,175 shares at $20.81 ($399,055)
  3. 4 Open-market sale Chief Medical Officer sold 57,308 shares at an average $18.00 ($1,031,769)
  4. 4 Open-market sale Chief Medical Officer sold 38,567 shares at an average $18.09 ($697,763)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $22.96 ($229,642)
  12. 4 Open-market sale Director sold 4,377 shares at $31.54 ($138,063)
  13. 4 Open-market sale 10% owner sold 4,377 shares at $31.54 ($138,063)
  14. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $29.61 ($296,137)
  15. 4 Open-market sale Vice President, Finance sold 1,343 shares at an average $31.26 ($41,981)
  16. 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $27.00 ($270,026)
  17. 4 Open-market sale Chief Development Officer sold 15,000 shares at an average $27.00 ($404,958)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 16 · 301 filings